Benign Conditions

Latest News

Liposomal tacrolimus shows promise for hemorrhagic cystitis
Liposomal tacrolimus shows promise for hemorrhagic cystitis

September 21st 2023

Liposomal tacrolimus led to improvements in hematuria, bleeding sites on cystoscopy, microscopic urine analysis for red blood cells, and urinary symptoms.

blue tinted photo of a stethoscope lying on a laptop keyboard
ChatGPT has limitations in providing advice on urologic conditions

September 8th 2023

Advanced UTI test demonstrates financial and outcomes-based benefits over standard urine culture
Advanced UTI test demonstrates financial and outcomes-based benefits over standard urine culture

June 23rd 2023

Rethinking creatinine to estimate kidney function in non–weight-bearing individuals
Rethinking creatinine to estimate kidney function in non–weight-bearing individuals

April 6th 2023

Harvesting a rectal mucosa graft using the single-port robotic system for a substitution urethroplasty
Harvesting a rectal mucosa graft using the single-port robotic system for a substitution urethroplasty

April 5th 2023

Latest CME Events & Activities

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Register Now!

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Register Now!

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

Community Practice Connections™: 16th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

View More

How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies

View More

Medical Crossfire®: Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?

View More

Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies

View More

Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer

View More

Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?

View More

Community Practice Connections™: What the Community Needs to Know to Apply RLT in PSMA-Positive mCRPC in Context with Current Treatment Paradigms

View More

More News

© 2023 MJH Life Sciences

All rights reserved.